A million viewers chase a young medical PhD on Douyin after Zhang Xuefeng’s death

A sudden star born at a tense moment

A Swedish-based medical PhD student known online as Dr. Piankouyu (偏口鱼博士) has gone from modest audiences to livestreams drawing over a million views. He began posting medical-popularization videos on Douyin (抖音) in November 2023 and, it has been reported that, surged in popularity around the March 15 consumer-rights period and again after the shock of public figure Zhang Xuefeng (张雪峰) dying suddenly at 41 — a death that focused national attention on middle‑age health and workplace stress. Short, blunt and delivered with a Northeastern accent, his mix of debunking pseudo‑science and practical advice landed with young users.

Platform power: algorithm meets a public mood

Reportedly, third‑party data shows nearly 80% of Dr. Piankouyu’s live traffic has come from Douyin’s recommendation streams — far above peers’ averages — suggesting platform promotion, not just organic word‑of‑mouth, has played a major role. Douyin and parent ByteDance (字节跳动) have been publicly ramping up medical and public‑interest content; it has been reported that the platform’s medical‑science content has racked up hundreds of billions of views. In China’s tightly regulated tech environment, platforms also face incentives to surface “positive” public‑service figures to rebuild social trust after prior controversies.

Why this voice, why now?

Part of the appeal is demographic fit. It has been reported that about 80% of his followers are under 40 and 26% are aged 18–23 — a much younger cohort than many established medical channels. He speaks the language of anxious millennials and Gen Z: concise, colloquial, and focused on everyday risks like cardiac arrest, sleep and diet. And timing matters. Zhang Xuefeng’s death catalyzed a wave of health anxiety among young professionals asking, how to live and work without burning out? Dr. Piankouyu’s content answers that question in a format that users both consume and signal to the algorithm (likes, saves, shares), which in turn amplifies reach.

A created star — for how long?

China’s short‑video platforms have a history of “making” figures who ride a moment. From charity profiles to lifestyle influencers, algorithmic boosts can build huge audiences fast. But creation isn’t permanence. Will Dr. Piankouyu sustain this attention once the immediate emotion fades? Platforms can nudge, and geopolitics and domestic regulation shape incentives, but longevity will depend on whether an individual creator can convert fleeting viral reach into durable trust and repeat value for viewers.